Navigation Links
Orexigen Therapeutics to Present Data on Contrave Impact on,Visceral Fat and Insulin Resistance at American Diabetes,Association 67th Scientific Sessions in Chicago June 23

SAN DIEGO, June 21, 2007 /PRNewswire-FirstCall/ -- Orexigen(TM) Therapeutics, Inc. , a biopharmaceutical company focused on the treatment of central nervous system disorders with an initial focus on obesity, today announced that the Company will present data about its lead obesity product candidate Contrave(TM) and its effect on markers of cardiovascular disease (visceral fat, serum cholesterol, and triglycerides) and insulin-resistance. The findings come from additional analyses of the Phase IIb multi-center clinical trial of Contrave. The data will be presented on Saturday, June 23rd, 6:00-7:15 pm and Monday, June 25th, 2007 at the 67th Annual Scientific Sessions of the American Diabetes Association (ADA) in Chicago, IL. Contrave data can be found in category 20B, poster number 45LB entitled, "Weight Loss with Bupropion and Naltrexone Improves Markers of Insulin-Resistance."

Contrave is a proprietary fixed dose combination of bupropion SR (sustained release) and Orexigen's novel formulation of naltrexone SR in a single tri-layer tablet. In a Phase IIb multi-center clinical trial, Contrave demonstrated statistically significant weight loss at 24 weeks compared to bupropion SR alone, naltrexone IR (immediate release) alone, and placebo. Contrave is now being studied in two separate multi-center Phase III studies, one of which is designed to further assess its safety and efficacy in obese subjects with Type II diabetes.

About Orexigen Therapeutics

Orexigen(TM) Therapeutics, Inc. is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system disorders, with an initial focus on obesity. Orexigen's lead combination product candidates targeted for obesity are Contrave(TM), which is in Phase III clinical trials, and Empatic(TM) (formerly Excalia(TM)), which is in a Phase IIb clinical trial. Both product candidates take ad
'"/>




Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
9. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
10. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
11. Barrier Therapeutics Announces Liarozole Phase 2/3 Study Results in Lamellar Ichthyosis

Post Your Comments:
(Date:11/19/2009)...ire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (...ublic offering of 5,000,000 shares of its common s...ds of $48.75 million. All of the shares are being...f registration statement previously filed with the... also granted the underwriters a 30-day option to ...
(Date:11/19/2009)...wswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. ...e presentation will be webcast live during the 21s...ednesday, December 2, 2009 at 9:00 a.m. Eastern Ti... York Palace Hotel in New York and will be present...,, To access the live presentation via the Web,...
(Date:11/19/2009)... As the seasons change, another season of coughs a... yourself. ,, Listen to this report from Ortho-...ttp://inr.mediaseed.tv/oneClip_C/?feed=ksLp_frMYEE...sion of The NewsMarket. Registered journalists ca...t http://www.thenewsmarket.com . ,, 10NY09-0...
Breaking Medicine Technology:BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Kornberg Associates Architects Selected to Develop Design for New Stanford University Imaging Center 12810 1Kornberg Associates Architects Selected to Develop Design for New Stanford University Imaging Center 12810 2GP bodies support guidelines for use of patient records in medical research 50226 1GP bodies support guidelines for use of patient records in medical research 50226 2New trigger for chronic inflammation in rheumatoid arthritis discovered 9028 1New trigger for chronic inflammation in rheumatoid arthritis discovered 9028 2
(Date:11/20/2009)...o Understanding Brain Wiring and Diseases ,, WA...eremy Schmahmann, Professor of Neurology at Harvar...tts General Hospital in Boston, on Thursday, Novem... new field of study called "Connectivity" at the l...mann is an award-winning leader in the field of th...
(Date:11/20/2009)...gressmen in Competitive Re-election Battles Could ... Washington, DC (Vocus) November...re-election next year in races deemed to be compet...regret voting for House Speaker Nancy Pelosi&rsquo... International/ O’Leary Report poll. (The ...
(Date:11/20/2009)...RNewswire-USNewswire/ -- Samuel Gladding is no Scr...eans to be "happy" during the holidays. As a licen...ily counseling and chair of the Department of Coun...search shows that it is the pressure to be happy t...ing the holidays. ,, That,s why he,s challengin...
(Date:11/20/2009)... with chronic kidney disease often fail to detect ...increasing a child,s risk for serious heart proble...ren,s Center and other institutions. A report of t...can Society of Nephrology. , Researchers compa...gular doctor visits to readings obtained via a spe...
(Date:11/20/2009)...n with seasonal flu , , FRIDAY, Nov. 20...rting that children with asthma are more likely to...u. , "Asthma has been identified as a significa...fluenza, present in 21 percent to 30 percent in th...w researchers from the Hospital for Sick Children ...
Breaking Medicine News(10 mins):Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:High blood pressure easy to miss in children with kidney disease 2
...holic Charities,USA today urged Congress and the W...ad come together to pass a comprehensive children,... is scheduled to vote on a compromise bill to,reau...he program will expire on September 30th unless le...
...cientists will announce today (Monday September 24...for anti-tumour therapy in cancer. Professor Saver...undation, Chieti, will tell the European Cancer Co... development of novel diagnostic and therapeutic p...
...n Saturday,September 29, 2007, the American Societ...tion and Obesity Action Coalition (OAC) are set to... cities across the United States. This weekend, t...y. This year,s Walk invites friends, family member...
...agement & Technology,Consultants, Inc. (Nasdaq: D...xperience includes senior executive positions at S...ned the firm as a partner in its healthcare,practi...onsumer health, and payors. His portfolio of exper...
...Purple Drink Craze in NYC, NEW YORK, Sept. 24 Tr...same in New York City hot spots, where high-antiox...lar acai berry are making their,way to cocktail gl...ck the promise of an antioxidant boost along with ...
...? Stressed? Achy? Looking,for a simple way to rela...http://www.thevillagecompany.com ), a leader in ad...es the nationwide launch of its Village Naturals,T...ve and busy American,s most,universal ailments, Vi...
Other Medicine News:Health News:Catholic Charities USA Calls on Congress and the President to Protect the Health of Children; Urges President Not to Veto Vitally Important Bill 2Health News:Catholic Charities USA Calls on Congress and the President to Protect the Health of Children; Urges President Not to Veto Vitally Important Bill 3Health News:Discovery of widespread tumor growth gene holds promise for effective anti-cancer treatment 2Health News:Discovery of widespread tumor growth gene holds promise for effective anti-cancer treatment 3Health News:Help Raise Awareness of Obesity - Annual 'Walk From Obesity' Invites Participants to Join a Walk in Their Local Area 2Health News:Healthcare Veteran Richard Findlay Joins Diamond Management & Technology Consultants as Partner 2Health News:Purple: The Hottest Color for Fall in Shoes, Handbags and Martinis 2Health News:The Village Company Unveils Natural Bath and Body Solutions for Everyday Ailments 2
...nough to shuttle easily between offices in its opt...nn standard 30 cm radius bowl. Color LCD display, ..., 24-2, and 10-2) to test full/normal, fast and 3 ... so accurate, no second perimeter verification is ...
...onal hardware and software features to meet with t...eaching institutions. Standard with B/Y perimetry....erimental or clinical studies. Ethernet connection...further tests including Flicker- and Color perimet...
...isual field testing that's so efficient it can eve...visual field instrument that's simple enough, fast...-test. Affordably priced FDT has years of research...ance. The instrument produce screening results in ...
Focus Dailies Toric
Medicine Products: